Vaxcyte, Inc. PCVX EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s EBIT?
- Vaxcyte, Inc. (PCVX) reported EBIT of -$345.85M in Q1 2026.
- How has Vaxcyte, Inc.'s EBIT changed year-over-year?
- Vaxcyte, Inc.'s EBIT decreased by 91.3% year-over-year, from -$180.79M to -$345.85M.
- What is the long-term trend for Vaxcyte, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s EBIT has grown at a 72.8% compound annual growth rate (CAGR), from -$103.67M to -$923.68M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.